ACRV logo
ACRV NASDAQ US

Acrivon Therapeutics, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Nov 2022
$1.52
▲ +$0.06 (+4.11%)
Vol 392K
2
Quality Score
fail
Mkt Cap
$76.0M
ROE
-53.7%
D/E
0.00
Beta
1.82
52W
$1–$8

Wall Street Consensus

15 analysts · Apr 2026
4
Strong Buy
9
Buy
2
Hold
0
Sell
0
Strong Sell
86.7%
Buy Rating

Price Chart

Similar Stocks

ACET
Adicet Bio Inc
$80.7M
CTOR
Citius Oncology Inc
$84.8M
CLNN
Clene Inc
$60.7M
ACTU
Actuate Therapeutics Inc
$142.2M
OKUR
Onkure Therapeutics Inc
$39.3M
ICCC
ImmuCell Corp
P/E 23.9
$55.6M
TIL
Instil Bio Inc
$74.6M
KZR
Kezar Life Sciences Inc
$46.1M

Earnings

Beat rate: 80.0%
Next Report May 12, 2026
EPS Estimate: $-0.54
Quarter EPS Est EPS Act Surprise
Mar 2026 $-0.54 — —
Dec 2025 $-0.48 $-0.52 $-0.04
Sep 2025 $-0.60 $-0.47 +$0.13
Jun 2025 $-0.60 $-0.55 +$0.05

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -50.8% -50.8% -50.8% -50.8% -50.8% -53.7%
P/E (TTM) — — — — — —
Net Margin — — — — — —
Gross Margin — — — — — —
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 10.31 10.31 10.31 10.31 10.31 8.75

Key Ratios

ROA (TTM)
-48.3%
P/B
1.1
EPS (TTM)
$-2.13
CF/Share
$-2.25
52W High
$8.00
52W Low
$1.05
$1.05 52-Week Range $8.00

How does ACRV compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

ACRV AAPG ABEO ABOS ABP

ACRV valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
—
▼ 0% below peers (12.9)
vs Peers
vs Industry
Overvalued
P/B ratio
1.1
▼ 57% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

ACRV profitability vs Biotechnology peers

ROE
-53.7%
▲ 20% above peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
—
▼ 0% below peers (-286.8%)
vs Peers
vs Industry
Top tier
Gross margin
—
▼ 0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-48.3%
▼ 3% below peers (-46.7%)
vs Peers
vs Industry
In line

ACRV financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
8.8
▲ 97% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.8
▲ 88% above peers (1.0)
vs Peers
vs Industry
More volatile

ACRV fundamentals radar

ACRV Peer median Industry

ACRV profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

ACRV vs peers: key metrics

Latest News

No related news yet